1. Price DA, Porter LE, Gordon M, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 1999; 10:2382–2391. PMID:
10541298.
Article
2. Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012; 367:2204–2213. PMID:
23121378.
Article
3. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenalrenin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59:251–287. PMID:
17878513.
4. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenalangietensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol. 2011; 11:180–186. PMID:
21339086.
5. Matsusaka T, Niimura F, Shimizu A, et al. Liver angiotensinogen is the primary source of renal angiotension II. J Am Soc Nephrol. 2012; 23:1181–1189. PMID:
22518004.
6. Prieto-Carrasquero MC, Kobori H, Ozawa Y, et al. AT1 receptor-mediated enhancement of collecting duct rennin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol. 2005; 289:F632–F637. PMID:
15870381.
7. Zhou A, Carrell RW, Murphy MP, et al. A redox switch in angiotensinogen modulates angiotensin release. Nature. 2010; 468:108–111. PMID:
20927107.
Article
8. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000; 87:E1–E9. PMID:
10969042.
Article
9. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000; 275:33238–33243. PMID:
10924499.
10. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002; 277:14838–14843. PMID:
11815627.
Article
11. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002; 417:822–828. PMID:
12075344.
Article
12. Tikellis C, Johnston CI, Forbes JM, et al. Characteriza tion of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003; 41:392–397. PMID:
12623933.
13. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2006; 290:C420–C426. PMID:
16176966.
Article
14. Esteban V, Heringer-Walther S, Sterner-Kock A, et al. Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One. 2009; 4:e5406. PMID:
19404405.
Article
15. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res. 2006; 98:1123–1133. PMID:
16690893.
16. Song SB, Jin HS, Hong KW, et al. Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population. Blood Press. 2011; 20:204–210. PMID:
21342026.
Article
17. Burrell LM, Harrap SB, Velkoska E, Patel SK. The ACE2 gene: Its potential as a functional candidate for cardiovascular disease. Clin Sci. 2013; 124:65–76. PMID:
23013041.
Article
18. Rentzsch B, Todiras M, Iliescu R, et al. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension. 2008; 52:967–973. PMID:
18809792.
Article
19. Luque M, Martin P, Martell N, et al. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 1996; 14:799–805. PMID:
8793704.
Article
20. Hernández Prada JA, Ferreira AJ, Katovich MJ, et al. Structure-basedidentification of small-moleculeangiotensin-converting enzyme 2 activators as novel antihyperten-siveagents. Hypertension. 2008; 51:1312–1317. PMID:
18391097.
21. Oudit GY, Liu GC, Zhong J, et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes. 2010; 59:529–538. PMID:
19934006.
Article
22. Wiemer G, Dobrucki LW, Louka FR, Malinski T, Heitsch H. AVE 0991, a nonpeptide mimic of the effect of angiotensin-(1-7) on the endothelium. Hypertension. 2002; 40:847–852. PMID:
12468568.
23. Shemesh R, Toporik A, Levine Z, et al. Discovery and validation of novel peptideagonists for G-protein-coupled receptors. J Biol Chem. 2008; 283:34643–34649. PMID:
18854305.